Insights, News, & Events arrow_right Deals & Advisory arrow_right Mergers & Acquisitions arrow_right

CM Life Sciences II Acquires SomaLogic, Inc.

Mergers & Acquisitions

SomaLogic, a privately-owned protein biomarker discovery and diagnostics company, was acquired by CM Life Sciences II (NASDAQ: CMII), a special purpose acquisition company, for $651 million.

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here.